Industries > Pharma > Pharma Clinical Trial Services Market and Industry Forecast 2020-2030

Pharma Clinical Trial Services Market and Industry Forecast 2020-2030

Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Disease

PUBLISHED: 20 March 2020
PAGES: 200
PRODUCT CODE: PHA0729

Clear
WOOCS 2.2.1

covid-19

The pharma clinical trials services market is expected to grow at a CAGR of 10% in the first half of the forecast period and be worth $150.15bn by 2030.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 220-page report you will receive 51 tables and 110 figures– all unavailable elsewhere.

The 220-page report provides clear detailed insight into the pharma clinical trial services market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Pharma Clinical Trial Services Market forecasts from 2020-2030

• This report breaks down the revenue forecast for pharma clinical trial services market by type of service:
• Early Phase Services
• Late Phase Services
• Other Services

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report breaks down the revenue forecast for pharma clinical trial services market by End-Users:
• Pharma
• Biotech Companies
• Other End-Users

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report breaks down the revenue forecast for pharma clinical trial services market by Therapeutic Area:
• Cancer
• Cardiovascular
• CNS
• Infectious Diseases
• Metabolic Diseases
• Other Diseases

Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2030 for these regional and national markets:
• North America: the US and Rest of North America
• Europe: France, Germany, the UK, Spain, Italy, Russia, Central and Eastern Europe, Rest of Europe
• Asia-Pacific: China, India, Japan, South Korea, Rest of APAC
• Rest of the World: Latin America, Middle East and Africa, Brazil

Each regional market is further divided by type of service, end-users and therapeutic area.

• Our study discusses factors that drive and restrain the pharma clinical trial services market. This report also provides a STEP analysis.

• This report discusses the leading companies in pharma clinical trial services market:
• Quintiles, Laboratory Corporation of America (LabCorp)
• Pharmaceutical Product Development (PPD)
• Parexel International
• ICON
• INC Research Holdings
• inVentiv Health
• & Other Companies

Pharma Clinical Trial Services Market and Industry Forecast 2020-2030

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma clinical trial services market. You find data, trends and predictions.

Buy our report today Pharma Clinical Trial Services Market and Industry Forecast 2020-2030: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharma Clinical Trial Services Market and Industry Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Pharma Clinical Trial Services Market and Industry Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories